Skip to main content
Erschienen in: Pediatric Nephrology 6/2004

01.06.2004 | Brief Report

The co-existence of Fabry and celiac diseases: a case report

verfasst von: Leyla Tümer, Fatih S. Ezgü, Alev Hasanoğlu, Buket Dalgıç, Sevcan A. Bakkaloğlu, Leyla Memiş, Ayşe Dursun

Erschienen in: Pediatric Nephrology | Ausgabe 6/2004

Einloggen, um Zugang zu erhalten

Abstract

We present a patient with Fabry disease with remarkable diagnostic findings and gluten-sensitive enteropathy. An 11-year-old girl was admitted to hospital with weight loss, anorexia, nausea, vomiting, flank pain, acroparesthesia, and painful extremities. Her mother had end-stage renal failure secondary to Fabry disease. On physical examination, she had growth retardation. Ophthalmological examination showed characteristic whorl-like corneal opacities and Fabry disease was confirmed with low α-galactosidase A (α-gal A) activity. Her painful attacks were treated with carbamazepine, but vomiting and nausea continued. Laboratory studies revealed positive serum anti-endomysium and anti-gliadin antibodies. Small intestinal biopsy showed subtotal villous atrophy compatible with gluten-sensitive enteropathy. Following treatment with a gluten-free diet, her gastrointestinal symptoms completely disappeared within a few weeks and then she had catch-up growth. In her long-term follow-up, proteinuria appeared and renal involvement was confirmed by characteristic renal biopsy findings. Following these clinicopathological findings, enzyme replacement therapy was started. In conclusion, although heterozygous females can be asymptomatic or are expected to have a mild course of the disease, a severe clinical course in our patient in the 2nd decade is of particular interest. In addition, Fabry disease occurring with gluten-sensitive enteropathy, a very rare co-existence, is emphasized.
Literatur
1.
Zurück zum Zitat Peters FJP, Vermeulen A, Kho Tl (2001) Anderson-Fabry disease: α-galactosidase deficiency. Lancet 357:138–140CrossRefPubMed Peters FJP, Vermeulen A, Kho Tl (2001) Anderson-Fabry disease: α-galactosidase deficiency. Lancet 357:138–140CrossRefPubMed
2.
Zurück zum Zitat Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AI, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, vol. 3, pp 3733–3774 Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AI, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, vol. 3, pp 3733–3774
3.
Zurück zum Zitat Whybra C, Kampmann C, Willers I, Davis J, Winchester B, Kreigsmann J, Brühl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherited Metab Dis 24:715–724CrossRefPubMed Whybra C, Kampmann C, Willers I, Davis J, Winchester B, Kreigsmann J, Brühl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherited Metab Dis 24:715–724CrossRefPubMed
4.
Zurück zum Zitat Lyon MF (1998) X-Chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet 80:133–137PubMed Lyon MF (1998) X-Chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet 80:133–137PubMed
5.
Zurück zum Zitat Sheth KJ, Werlin SL, Freeman ME, Hodach AE (1981) Gastrointestinal structure and function in Fabry disease. Am J Gastroenterol 76:246–251PubMed Sheth KJ, Werlin SL, Freeman ME, Hodach AE (1981) Gastrointestinal structure and function in Fabry disease. Am J Gastroenterol 76:246–251PubMed
6.
Zurück zum Zitat Halsted CH, Rowe JW (1975) Occurrence of celiac sprue in a patient with Fabry disease. Ann Intern Med 83:524–525PubMed Halsted CH, Rowe JW (1975) Occurrence of celiac sprue in a patient with Fabry disease. Ann Intern Med 83:524–525PubMed
7.
Zurück zum Zitat Knol IE, Ausems MG, Lindhout D, Diggelen OP van, Verwey H, Davies J, Ploos van Amstel JK, Poll-The BT (1999) Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation. Am J Med Genet 82:436–439CrossRefPubMed Knol IE, Ausems MG, Lindhout D, Diggelen OP van, Verwey H, Davies J, Ploos van Amstel JK, Poll-The BT (1999) Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation. Am J Med Genet 82:436–439CrossRefPubMed
8.
Zurück zum Zitat Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:S139–S143PubMed Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:S139–S143PubMed
9.
Zurück zum Zitat Breunig F, Wanner C (2003) Enzyme replacement therapy for Fabry disease: proving the clinical benefit. Nephrol Dial Transplant 18:7–9CrossRefPubMed Breunig F, Wanner C (2003) Enzyme replacement therapy for Fabry disease: proving the clinical benefit. Nephrol Dial Transplant 18:7–9CrossRefPubMed
10.
Zurück zum Zitat Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743–2749CrossRefPubMed Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743–2749CrossRefPubMed
11.
Zurück zum Zitat Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry disease. N Engl J Med 345:9–16 Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry disease. N Engl J Med 345:9–16
Metadaten
Titel
The co-existence of Fabry and celiac diseases: a case report
verfasst von
Leyla Tümer
Fatih S. Ezgü
Alev Hasanoğlu
Buket Dalgıç
Sevcan A. Bakkaloğlu
Leyla Memiş
Ayşe Dursun
Publikationsdatum
01.06.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 6/2004
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1462-8

Weitere Artikel der Ausgabe 6/2004

Pediatric Nephrology 6/2004 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.